Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Iterum Therapeutics Plc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Iterum Therapeutics Plc market cap is $528.00.
What is the 52-week high for Iterum Therapeutics Plc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Iterum Therapeutics Plc 52 week high is $0.831 as of August 22, 2026.
What is the 50-day moving average of Iterum Therapeutics Plc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Iterum Therapeutics Plc 50-day moving average is $0.0257.